Hillsdale Investment Management’s PharMerica Corporation PMC Stock Holding History

Hillsdale Investment Management’s Portfolio PMC Stock Details PMC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-330	Closed	-$8K	–	572
2016 Q4	$8K	Sell	330 -17,200	-98%	-$434K	﹤0.01%	374
2016 Q3	$492K	Buy	17,530 +2,000	+13%	+$51.3K	0.13%	138
2016 Q2	$383K	Buy	15,530 +2,000	+15%	+$49.6K	0.11%	186
2016 Q1	$299K	Hold	13,530	–	–	0.1%	271
2015 Q4	$474K	Sell	13,530 -3,100	-19%	-$97.1K	0.18%	87
2015 Q3	$473K	Buy	16,630 +8,930	+116%	+$300K	0.16%	105
2015 Q2	$256K	Buy	+7,700	New	+$236K	0.08%	310
2015 Q1	–	Sell	-13,200	Closed	-$273K	–	600
2014 Q4	$273K	Buy	+13,200	New	+$313K	0.07%	272

Other funds holding PMC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

DGI

Discovery Group I Chicago, Illinois $262M AUM 29.24% 1-Year Est. Return

Hillsdale Investment Management's PMC Position: Q1 2017 in Review

Hillsdale Investment Management sold out of PharMerica Corporation (PMC) in Q1 2017, closing a stake of 330 shares — an estimated $8K sold.

Hillsdale Investment Management first reported a position in PMC in Q4 2014 and held it in 8 quarters. The position peaked at $492K in Q3 2016. 152 funds tracked by Wall St. Rank hold PMC as of Q1 2017.

Hillsdale Investment Management reported no remaining PharMerica Corporation position as of Q1 2017 after selling out during the quarter.
Hillsdale Investment Management sold 330 PharMerica Corporation shares in Q1 2017, an estimated $8K.
Hillsdale Investment Management first reported a position in PharMerica Corporation in Q4 2014 and held it in 8 quarters.
Hillsdale Investment Management's PharMerica Corporation position peaked at $492K in Q3 2016.
152 funds tracked by Wall St. Rank held PharMerica Corporation as of Q1 2017.

Based on Hillsdale Investment Management's 13F filing for Q1 2017, filed 9 May 2017.